What's new? Log in Free sign up

Oscient Pharmaceuticals (OSCI) Inactive

Company Profile

Company profile

Ticker

OSCI

Website

www.osceolagoldinc.com

CEO

Christopher Tarquinio

Incorporated

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris • AbbVie • Bausch Health Companies ...

Former names

Genome Therapeutics Corp

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

IRS number

42297484

Latest filings (excl ownership)

View all

Exchange delisting

Bankruptcy or Receivership

Cost Associated with Exit or Disposal Activities

Oscient Pharmaceuticals Receives NASDAQ Letter Regarding

Notice of late quarterly filing

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Latest ownership filings

No filings

Press releases

From Benzinga Pro

Osceola Gold, Inc Announces Submission of Financial Reports and Upcoming Resumption of Mining Operations

ELY, NV / ACCESS Newswire / January 17, 2025 / Osceola Gold, Inc. (OTC:OSCI), a junior gold mining, exploration and consulting company, is pleased to announce that it has completed and updated its financial reports

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.